Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cyclin and cell cycle]

S Inoue1

  • 1Dept. of Environmental Medicine and Informatics, Graduate School of Environmental Earth Science, Hokkaido University, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification and amino-acid sequence of a nerve growth factor from the venom of Vipera russelli russelli.

Biochimica et biophysica acta·1992
Same author

Fish egg glycophosphoproteins have species-specific N-linked glycan units previously found in a storage pool of free glycan chains.

The Journal of biological chemistry·1992
Same author

Successful pancreatojejunal anastomosis for pancreatoduodenectomy.

Surgery, gynecology & obstetrics·1992
Same author

QRS complex changes in the V5 ECG lead during cardiac surgery.

Journal of cardiothoracic and vascular anesthesia·1992
Same author

[Autonomic function and severity of hypertrophic cardiomyopathy by power spectrum analysis on heart rate variability].

Kokyu to junkan. Respiration & circulation·1992
Same author

Stimulation of glucose transport by guanine nucleotides in permeabilized rat adipocytes.

Biochemical and biophysical research communications·1992
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Cancer cells exhibit cell cycle dysregulation, including altered cyclin and CKI levels, impacting treatment sensitivity. Understanding these cell cycle defects offers potential for novel anti-cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Biology

Background:

  • The cell cycle is a tightly regulated process involving cyclins and cyclin-dependent kinases (Cdks) for normal cell growth, differentiation, and apoptosis.
  • Cell cycle progression is controlled by checkpoints that detect and repair errors, ensuring genomic stability.
  • Cancer cells frequently display dysregulated cell cycle components, such as aberrant cyclin expression and loss of CKI function.

Purpose of the Study:

  • To elucidate the role of cell cycle regulators in normal and cancerous cells.
  • To investigate how cell cycle abnormalities contribute to cancer development and progression.
  • To explore the potential of targeting cell cycle components for cancer therapy.

Main Methods:

  • Analysis of cyclin and Cdk expression patterns in normal and cancer cells.

Related Experiment Videos

  • Investigation of cyclin-dependent kinase inhibitor (CKI) function and regulation.
  • Examination of cell cycle checkpoint control mechanisms and their failure in cancer.

    • Main Results:

    • Cancer cells often exhibit overexpression of cyclins and mutations or deletions in CKIs.
    • Failures in cell cycle checkpoints are common in cancer cells, leading to uncontrolled proliferation.
    • These cell cycle abnormalities correlate with patient prognosis and sensitivity to chemotherapy and irradiation.

    Conclusions:

    • Dysregulation of cell cycle components is a hallmark of cancer.
    • Understanding these molecular defects provides a basis for evaluating cancer prognosis and treatment response.
    • Targeting aberrant cell cycle pathways holds promise for developing new anti-cancer drugs.